Pitliya Anmol, Pitliya Aakanksha, Vasudevan Srivatsa Surya, Yadav Kumari Priya, Shabbir Muhammad Bilal, Zahoor Shaghaf, Shabbir Aisha, Ibrahim Abdulgafar Dare, Jeswani Bijay Mukesh, Jonnala Ramya Reddy, Singla Ramit
Department of Hospitalist Medicine, Camden Clark Medical Center, Parkersburg, WV, USA.
Department of Internal Medicine, Mercy Catholic Medical Center, Darby, PA, USA.
Egypt Heart J. 2024 Nov 22;76(1):153. doi: 10.1186/s43044-024-00585-0.
The ideal treatment strategy for spontaneous coronary artery dissection (SCAD) remains unclear, with patients potentially treated with either conservative medical care or a revascularization approach.
We performed a systematic review and meta-analysis adhering to PRISMA 2020 guidelines. Inclusion criteria involved studies with confirmed SCAD diagnosis, reporting initial management strategies, and original research with ≥ 10 participants. Random-effect models were applied for insignificant heterogeneity with significance at p ≤ 0.05. Sensitivity analysis and funnel plots assessed potential publication bias.
Our analysis found no significant differences in major adverse cardiac events (MACE) (OR = 0.61, p = 0.49), unstable angina pectoris (UAP) (OR = 1.04, p = 0.93), non-ST segment elevation myocardial infarction (NSTEMI) (OR = 1.16, p = 0.82), recurrent myocardial infarction (MI) (OR = 0.78, p = 0.56), stroke (OR = 0.35, p = 0.07), heart failure (OR = 0.41, p = 0.24), in-hospital mortality (OR = 0.35, p = 0.09), post-discharge mortality (OR = 1.66, p = 0.27), or ST segment elevation myocardial infarction (STEMI) (OR = 0.45, p = 0.23) between conservative management and revascularization procedures. However, sensitivity analysis reveals significant decreases in odds of inferior wall STEMI (OR = 0.41 [95% CI 0.17-0.97], p = 0.04) and heart failure (OR = 0.18 [95% CI 0.06-0.54], p = 0.002) in conservative treatment compared to revascularization group.
Conservative therapy significantly decreased inferior wall STEMI and heart failure as compared to revascularization in SCAD. Although no significant differences in cardiovascular outcomes, sensitivity analysis highlights potential benefits of conservative management.
自发性冠状动脉夹层(SCAD)的理想治疗策略仍不明确,患者可能接受保守药物治疗或血运重建治疗。
我们按照PRISMA 2020指南进行了系统评价和荟萃分析。纳入标准包括确诊为SCAD的研究、报告初始治疗策略以及样本量≥10例参与者的原始研究。对于异质性不显著的情况,采用随机效应模型,显著性水平为p≤0.05。敏感性分析和漏斗图评估潜在的发表偏倚。
我们的分析发现,在主要不良心脏事件(MACE)(OR = 0.61,p = 0.49)、不稳定型心绞痛(UAP)(OR = 1.04,p = 0.93)、非ST段抬高型心肌梗死(NSTEMI)(OR = 1.16,p = 0.82)、复发性心肌梗死(MI)(OR = 0.78,p = 0.56)、中风(OR = 0.35,p = 0.07)、心力衰竭(OR = 0.41,p = 0.24)、住院死亡率(OR = ?0.35,p = 0.09)、出院后死亡率(OR = 1.66,p = 0.27)或ST段抬高型心肌梗死(STEMI)(OR = 0.45,p = 0.23)方面,保守治疗和血运重建治疗之间无显著差异。然而,敏感性分析显示,与血运重建组相比,保守治疗组下壁STEMI的发生率(OR = 0.41 [95% CI 0.17 - 0.97],p = 0.04)和心力衰竭的发生率(OR = 0.18 [95% CI 0.06 - ×0.54],p = 0.002)显著降低。
与SCAD的血运重建治疗相比,保守治疗显著降低了下壁STEMI和心力衰竭。尽管心血管结局无显著差异,但敏感性分析突出了保守治疗的潜在益处。
原文中“住院死亡率(OR = ?0.35”和“心力衰竭的发生率(OR = 0.18 [95% CI 0.06 - ×0.54]”疑似有错误表述,但按照要求未做修改。